Abbott gains FDA nod for blood Dx; Some pacemaker plastics appear to degrade;

 @FierceMedDev: SurgiQuest pulled in $18.5M in new funding for an abdominal cavity surgical tool. Release | Follow @FierceMedDev

@MarkHFierce: Another day, another lawsuit against a faulty metal hip replacement--this time against Biomet. Story | Follow @MarkHFierce

 @DamianFierce: The Israeli medical device industry is on the up-and-up, and Medtronic is paying attention, an exec says. News | Follow @DamianFierce

> Abbott Laboratories ($ABT) got FDA approval for the Architect AFP assay, a blood diagnostic designed to aid in cancer management and detect openings of the brain or spinal cord. More

> Sorin Group ($SRN) notched its first North American implant of the Paradym implantable defibrillator. News

> Micro Machine, a device manufacturer that works with DePuy and Zimmer ($ZMH), is expanding its Warsaw, MI, plant and hiring 60 people. Article

> MichBio, a Michigan life sciences industry association, is joining the Medical Device Innovation Consortium, a public-private outfit uniting the FDA, devicemakers and trade groups. Release

> Contract manufacturer Laserage is expanding into the medical device world with its acquisition of a majority interest in Venta Medical, a California device CMO. Item

> The FDA is looking for industry nominees to join CDRH's Device Good Manufacturing Practice Advisory Committee as a non-voting member. Story

> Some silicone-urethane plastics used for devices such as pacemakers and defibrillators degrade in a previously unknown way. Story

Biotech News

 @FierceBiotech: In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Story | Follow @FierceBiotech

 @JohnCFierce: At the very least, Merck should redesign the patient selection process on MK-8931 and concentrate on mild/prodomal Alzheimer's cases only. | Follow @JohnCFierce

 @RyanMFierce: AstraZeneca has answered German price cuts to drugs with $AZN workforce cuts of 400-650 workers in the country. Release | Follow @RyanMFierce

> FDA blamed for stymying new antibiotics. Story

> Chelsea Therapeutics sinks on latest PhIII results of lead fainting med. News

> German biotech Wilex slashes staff after Phase III misfire. Report

Pharma News

@FiercePharma: Eli Lilly taps India's Strides Arcolab to make/distribute generic cancer drugs in emerging markets. More | Follow @FiercePharma

> Closely-watched Novartis patent case wraps in India. Story

> AZ blames German pricing for up to 625 job cuts. Article

Drug Delivery News

> Leukemia nanoparticles get drugs to the right spot. News

> Team shoos away superbugs with puffs of powder. Report

> Iluvien stumbles on rocky road to market in U.K. Article

> Dissolving fabric could stop pregnancy, HIV. Story

Biomarkers News

> Experts: Britain's NHS must build genetic testing infrastructure. News

> In Alzheimer's mystery, key biomarker will determine success of pivotal studies. Article

> Supreme Court to tackle gene patent case. Item

> Gene analysis marks new targets against childhood cancer. Report

> Biotech grabs $2M to discover biomarkers for personalized autism treatment. News

> Biomarker spotted for colon cancer stem cells. Story

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.